Received Oct 6, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | 2737J | — |
Itchiness all over the body after Shingrix second dose administration; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of generalized pruritus in a 64-year-old male patient who received Herpes zoster (Shingrix) (batch number 2737J, expiry date 23-SEP-2025) for prophylaxis. On 30-JAN-2024, the patient received the 2nd dose of Shingrix. In FEB-2024, 2 weeks after receiving Shingrix, the patient experienced generalized pruritus (Verbatim: Itchiness all over the body after Shingrix second dose administration). The patient was treated with gabapentin. The outcome of the generalized pruritus was unknown. It was unknown if the reporter considered the generalized pruritus to be related to Shingrix. It was unknown if the company considered the generalized pruritus to be related to Shingrix. Additional Information: GSK receipt date: 16-SEP-2025 A pharmacist wanted to get safety information on the appearance of itchiness all over the body after 2 weeks since he received the second dose of Shingrix. He also mentioned to start with a restrictive diet and taking Gabapentin after this.